Low-Frequency versus High-Frequency Ultrasound-Mediated Transdermal Delivery of Agomelatine-Loaded Invasomes: Development, Optimization and in-vivo Pharmacokinetic Assessment

AIM: Agomelatine (AGM) is the first melatonergic antidepressant. It suffers from low oral bioavailability (<5%) due to extensive hepatic metabolism. The current work aimed to develop an alternative AGM-loaded invasomes to enhance transdermal drug bioavailability. METHODOLOGY: AGM-loaded invasomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Tawfik, Mai Ahmed, Tadros, Mina Ibrahim, Mohamed, Magdy Ibrahim, Nageeb El-Helaly, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669507/
https://www.ncbi.nlm.nih.gov/pubmed/33209023
http://dx.doi.org/10.2147/IJN.S283911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669507/
https://www.ncbi.nlm.nih.gov/pubmed/33209023
http://dx.doi.org/10.2147/IJN.S283911

Ejemplares similares